Versant Capital Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18K Hold
45
﹤0.01% 2624
2026
Q1
$1.13K Buy
+45
New +$1.06K ﹤0.01% 2639
2025
Q2
Sell
-12
Closed -$143 2745
2025
Q1
$143 Buy
+12
New +$164 ﹤0.01% 2479

Other funds holding ZYME

Versant Capital Management's ZYME Position: Q2 2026 in Review

Versant Capital Management held its Zymeworks (ZYME) position steady in Q2 2026 at 45 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

Versant Capital Management first reported a position in ZYME in Q1 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Versant Capital Management held 45 shares of Zymeworks worth $1.18K as of Q2 2026.
  • Versant Capital Management left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2624 holding.
  • Versant Capital Management first reported a position in Zymeworks in Q1 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.